Wei Li, Ph.D. | Acting Chief Executive Officer
Prior to joining WuXi Healthcare Ventures, Dr. Li focused his effort on healthcare and life science investment opportunities at Fidelity Biosciences, Fidelity Growth Partner Asia, and Baird Venture Partners. He also led drug discovery projects and technology licensing due diligence at Vertex Pharmaceuticals, a biotech company in Boston, MA. During his scientific career, Wei first-authored numerous scientific publications in journals including Science, Proceedings of the National Academy of Sciences, and the Journal of Biological Chemistry. Wei received a B.S., with distinction, in Chemical Physics from University of Science and Technology of China, a Ph.D. in Biochemistry and Mammalian Genetics from Harvard University, and an MBA from the Kellogg School of Management at Northwestern University, where he was elected Beta Gamma Sigma, with a concentration in Finance, Accounting and Marketing.
Feng Cao, Ph.D. | Chief Operating Officer
Dr. Cao joins AltheaDx with over fifteen years of experience in the molecular diagnostics space. Before expanding to lead Operations, Dr. Cao was AltheaDx’s VP of Software Development and Informatics, where he was responsible for the combined use of genetics, algorithm, and analytics to improve our IDgenetix® tests. Prior to joining AltheaDx, Dr. Cao held management positions at Hologic and Third Wave Technologies where he launched the Invader Call Reporter® software for molecular diagnostic IVD tests. Dr. Cao earned his doctorate in Cell Biology from Medical College of Wisconsin, his master’s degree in Computer Science from Marquette University, and his bachelor’s degree in Biology from Peking University.
Kimberly Wilson | Quality, Regulatory, and Compliance
With over twenty years of combined experience in preclinical research, diagnostic and medical device industries, Ms. Wilson brings her expertise as head of Quality, Regulatory, and Compliance at AltheaDx. She is responsible for the development, implementation and oversight of AltheaDx’s quality, regulatory, and compliance systems and programs. Ms. Wilson joined AltheaDx in 2008 and was instrumental in establishing the quality system, licensing, and accreditation for AltheaDx’s clinical laboratory. Ms. Wilson earned a B.S in Liberal Studies from National University. She is a member of Health Care Compliance Association and has served as a Director for the Pacific Regional Chapter of the Society of Quality Assurance.